EMA Backs Approval Of Novo Nordisk's Ozempic 2mg Dose For Diabetes

Loading...
Loading...
Posted In: BiotechNewsHealth CareGeneralBriefsEuropean Medicines Agency
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...